ICD-10 Coding for Breast DCIS(C50.312, C50.312B, C50.312M)
Comprehensive guide on ICD-10 coding for breast DCIS, including documentation requirements, common pitfalls, and billing considerations.
Complete code families applicable to Breast DCIS
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C50.312 | Malignant neoplasm of upper-outer quadrant of left female breast | Use when DCIS is confirmed in the upper outer quadrant of the left breast. |
|
| D05.10 | Intraductal carcinoma in situ of unspecified breast | Use when DCIS is confirmed but specific site or laterality is not documented. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutBreast DCIS
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Breast DCIS.
Omitting laterality in documentation
Impact
Clinical: Leads to incorrect treatment planning., Regulatory: Increases risk of non-compliance., Financial: Potential for denied claims.
Mitigation
Use standardized templates, Regular training on documentation
Using unspecified codes when specific site is documented
Impact
Reimbursement: May lead to lower reimbursement rates., Compliance: Increases risk of audit failures., Data Quality: Reduces accuracy of clinical data.
Mitigation
Ensure documentation specifies laterality and quadrant for accurate coding.
Unspecified Codes
Impact
High use of unspecified codes can trigger audits.
Mitigation
Implement documentation checks to ensure specificity.